• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Zinzino: ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026

Zinzino

Zinzino group revenue increased with a total of 26 % in Q1 compared with the previous year.

 

The revenue in March for Zinzino's sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. Faun Pharma's external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year.

The group revenue increased with 26 % for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million.

Revenues were distributed as follows:

Regions, mSEK

26-mar

25-mar

Change

Q1 2026

Q1 2025

Change

The Nordics

27.1

26.6

2%

77.7

77.1

1%

Central Europe

103.3

69.6

48%

274.9

196.4

40%

East Europe

29.5

34.0

-13%

85.1

97.2

-12%

South & West Europe

59.2

42.9

38%

155.7

124.9

25%

The Baltics

10.3

9.4

10%

29.2

28.7

2%

North America

80.2

56.1

43%

188.7

110.3

71%

South America

4.3

0.6

617%

11.8

2.3

413%

Asia-Pacific

25.9

24.6

5%

66.8

65.8

2%

Africa

2.4

2.0

          20%

6.5

5.0

          30%

Zinzino

342.2

265.8

29%

896.4

707.7

27%

Faun Pharma

6.6

7.1

-7%

19.0

16.0

19%

Zinzino Group

348.8

272.9

28%

915.4

723.7

26%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island.

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com